Today's Microbiologists Put Microbes To Work In Cleanup

When the Exxon Valdez ran aground in March 1989, spilling millions of gallons of crude oil into Alaska's Prince William Sound, it precipitated one of the largest bioremediation projects ever undertaken. A team of scientists from Exxon Corp., the Environmental Protection Agency, and the state of Alaska infused the contaminated beaches with nutrients to speed the growth of native oil-eating microbes, accelerating their metabolism of oil. Exxon and EPA cleaned miles of beaches, and they generated

Written byHolly Ahern
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Many other companies are also turning to the use of microorganisms, particularly bacteria, in environmental applications such as bioremediation and producing clean fuels. Biological treatment of hazardous wastes--using bacteria to break down these wastes into compounds with reduced toxicity--is appealing because it is a lower-cost alternative to technologies like incineration or extraction of the hazardous material from contaminated soil or water. The fact that EPA is now favorably viewing bioremediation as an alternative to more conventional technologies has encour- aged companies to support research in this area.

Bioremediation will be a widely discussed topic at the American Society of Microbiology's general meeting, to be held at the New Orleans Convention Center May 26-30. About 10,000 microbiologists are expected to attend the meeting, which will feature 2,600 presentations, including 316 seminars, symposia, and roundtables covering environmental, food, and clinical microbiology. Meeting highlights: President's Forum: "Biological Warfare: An Old Problem and Future ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies